Cyclazocine
Top View
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- III 1 J"I National Criminal Justice Reference Service '1 ! ,------II1
- Ingram Et Al, 2018 Ketamine As a Psychedelic, Revised
- The History of the Development of Buprenorphine As an Addiction Therapeutic
- Developmental Neurotoxicity of Ketamine in Pediatric Clinical Use
- Electrophysiological Interactions of Isomers of Cyclazocine with the Phencyclidine Antagonist Metaphit in Rat Cerebellar Purkinje Neurons
- Pentazocine, Cyclazocine, and Nalorphine As Discriminative Stimuli
- Literature Search Strategy for Treatment of Stable
- Partial Generalization in Pigeons Trained to Discriminate Morphine from Saline: Applications of Receptor Theory
- Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
- Cause Cerebral Arterial Spasm (Vascular Smooth Muscle/Basilar Artery/Middle Cerebral Artery/Psychotomimetic Activity/K Opiates) BELLA T
- Critical Review of BUTORPHANOL
- Use Patterns and Self-Reported Effects of Salvia Divinorum: an Internet-Based Survey
- Cross Discipline Team Leader Review
- Salvinorin A, a Kappa-Opioid Receptor Agonist Hallucinogen: Pharmacology and Potential Template for Novel Pharmacotherapeutic Agents in Neuropsychiatric Disorders
- Mediating Actions Ofbenzomorphan Drugs (Putative K and O' Agonists)
- The Chemistry of Salvia Divinorum
- Investigations of Salvinorin A: Synthetic Isolation, Quantification, and in Vivo Characteristics